Plasma Exchange for Immune Checkpoint Inhibitor–Induced Myocarditis

Immune checkpoint inhibitor therapy has been shown to improve outcomes across many types of malignancies. However, immune checkpoint inhibitor has been associated with several immune-related adverse events including myocarditis. We describe the case of a 69-year-old man with fulminant myocarditis li...

Descripción completa

Detalles Bibliográficos
Autores principales: Yogasundaram, Haran, Alhumaid, Waleed, Chen, June W., Church, Matthew, Alhulaimi, Naji, Kimber, Shane, Paterson, D. Ian, Senaratne, Janek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984993/
https://www.ncbi.nlm.nih.gov/pubmed/33778457
http://dx.doi.org/10.1016/j.cjco.2020.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984993/
https://www.ncbi.nlm.nih.gov/pubmed/33778457
http://dx.doi.org/10.1016/j.cjco.2020.11.004

Ejemplares similares